CA2473623C - Endoprothese recouverte et systeme de mise en place - Google Patents
Endoprothese recouverte et systeme de mise en place Download PDFInfo
- Publication number
- CA2473623C CA2473623C CA002473623A CA2473623A CA2473623C CA 2473623 C CA2473623 C CA 2473623C CA 002473623 A CA002473623 A CA 002473623A CA 2473623 A CA2473623 A CA 2473623A CA 2473623 C CA2473623 C CA 2473623C
- Authority
- CA
- Canada
- Prior art keywords
- segment
- endoprosthesis
- endoprosthesis according
- kgf
- stent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 abstract description 42
- 238000010276 construction Methods 0.000 abstract description 23
- 210000003240 portal vein Anatomy 0.000 abstract description 21
- 230000035699 permeability Effects 0.000 abstract description 13
- 238000004804 winding Methods 0.000 abstract description 12
- 239000012528 membrane Substances 0.000 abstract description 8
- 239000000463 material Substances 0.000 description 51
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 47
- 239000004810 polytetrafluoroethylene Substances 0.000 description 47
- 238000012360 testing method Methods 0.000 description 25
- 230000006835 compression Effects 0.000 description 19
- 238000007906 compression Methods 0.000 description 19
- 239000003570 air Substances 0.000 description 18
- 210000000941 bile Anatomy 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 14
- 229920009441 perflouroethylene propylene Polymers 0.000 description 14
- 210000002989 hepatic vein Anatomy 0.000 description 8
- 238000004806 packaging method and process Methods 0.000 description 8
- 238000006073 displacement reaction Methods 0.000 description 7
- 229910001000 nickel titanium Inorganic materials 0.000 description 7
- 239000000853 adhesive Substances 0.000 description 6
- 230000001070 adhesive effect Effects 0.000 description 6
- 239000002131 composite material Substances 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- -1 polytetrafluoroethylene Polymers 0.000 description 5
- 229910001220 stainless steel Inorganic materials 0.000 description 5
- 239000010935 stainless steel Substances 0.000 description 5
- 239000004677 Nylon Substances 0.000 description 4
- 238000005452 bending Methods 0.000 description 4
- 210000005228 liver tissue Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229920001778 nylon Polymers 0.000 description 4
- 238000001878 scanning electron micrograph Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000002439 hemostatic effect Effects 0.000 description 3
- 206010020718 hyperplasia Diseases 0.000 description 3
- 230000002390 hyperplastic effect Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 229920001169 thermoplastic Polymers 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 241000252233 Cyprinus carpio Species 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 235000019994 cava Nutrition 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229920002313 fluoropolymer Polymers 0.000 description 2
- 239000004811 fluoropolymer Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 210000004258 portal system Anatomy 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 238000009864 tensile test Methods 0.000 description 2
- 229920001187 thermosetting polymer Polymers 0.000 description 2
- 239000004416 thermosoftening plastic Substances 0.000 description 2
- 238000009966 trimming Methods 0.000 description 2
- 210000001631 vena cava inferior Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000010963 304 stainless steel Substances 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 208000035004 Device kink Diseases 0.000 description 1
- 208000036828 Device occlusion Diseases 0.000 description 1
- 229920000544 Gore-Tex Polymers 0.000 description 1
- 241000207836 Olea <angiosperm> Species 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 229910000589 SAE 304 stainless steel Inorganic materials 0.000 description 1
- 206010062243 Shunt malfunction Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 238000003490 calendering Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 239000000109 continuous material Substances 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 229940039231 contrast media Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 229910000701 elgiloys (Co-Cr-Ni Alloy) Inorganic materials 0.000 description 1
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 238000007431 microscopic evaluation Methods 0.000 description 1
- 230000002297 mitogenic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000036316 preload Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000003566 sealing material Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 238000005476 soldering Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000002885 thrombogenetic effect Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Landscapes
- Prostheses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23521999A | 1999-01-22 | 1999-01-22 | |
| US09/235,219 | 1999-01-22 | ||
| US09/489,604 | 2000-01-20 | ||
| US09/489,604 US6673102B1 (en) | 1999-01-22 | 2000-01-20 | Covered endoprosthesis and delivery system |
| CA002328999A CA2328999C (fr) | 1999-01-22 | 2000-01-21 | Endoprothese recouverte et systeme de mise en place |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002328999A Division CA2328999C (fr) | 1999-01-22 | 2000-01-21 | Endoprothese recouverte et systeme de mise en place |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2473623A1 CA2473623A1 (fr) | 2000-07-27 |
| CA2473623C true CA2473623C (fr) | 2008-10-28 |
Family
ID=32930828
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002473623A Expired - Lifetime CA2473623C (fr) | 1999-01-22 | 2000-01-21 | Endoprothese recouverte et systeme de mise en place |
| CA002503480A Expired - Lifetime CA2503480C (fr) | 1999-01-22 | 2000-01-21 | Endoprothese recouverte et systeme de mise en place |
| CA002473630A Expired - Lifetime CA2473630C (fr) | 1999-01-22 | 2000-01-21 | Endoprothese recouverte et systeme de mise en place |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002503480A Expired - Lifetime CA2503480C (fr) | 1999-01-22 | 2000-01-21 | Endoprothese recouverte et systeme de mise en place |
| CA002473630A Expired - Lifetime CA2473630C (fr) | 1999-01-22 | 2000-01-21 | Endoprothese recouverte et systeme de mise en place |
Country Status (1)
| Country | Link |
|---|---|
| CA (3) | CA2473623C (fr) |
-
2000
- 2000-01-21 CA CA002473623A patent/CA2473623C/fr not_active Expired - Lifetime
- 2000-01-21 CA CA002503480A patent/CA2503480C/fr not_active Expired - Lifetime
- 2000-01-21 CA CA002473630A patent/CA2473630C/fr not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2503480A1 (fr) | 2000-07-27 |
| CA2503480C (fr) | 2008-09-30 |
| CA2473630C (fr) | 2008-07-29 |
| CA2473630A1 (fr) | 2000-07-27 |
| CA2473623A1 (fr) | 2000-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2328999C (fr) | Endoprothese recouverte et systeme de mise en place | |
| US6673102B1 (en) | Covered endoprosthesis and delivery system | |
| JP7248749B2 (ja) | 直径を調節可能な内部人工器官ならびに関連したシステムおよび方法 | |
| US12453627B2 (en) | Low profile stent graft and delivery system | |
| CA2329213C (fr) | Combinaison de stent et de prothese endovasculaire a profil mince | |
| US20190192323A1 (en) | Controlled deployable medical device and method of making the same | |
| JP3280034B2 (ja) | よじれに抗するステント移植片 | |
| JP2001506902A (ja) | インプラント展開装置 | |
| JP6557281B2 (ja) | 低プロフィールステントグラフト及びデリバリシステム | |
| JP2002531219A (ja) | 多段階延伸膨張可能なステント/移植片 | |
| WO2000042948A9 (fr) | Combinaison de stent et de prothese endovasculaire a profil mince | |
| CA2473623C (fr) | Endoprothese recouverte et systeme de mise en place | |
| AU2007200411B2 (en) | Low profile stent and graft combination | |
| CA2505713C (fr) | Combinaison de stent et de prothese endovasculaire a profil mince | |
| AU2003248019A1 (en) | Low profile stent and graft combination |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20200121 |